Archon Capital Management’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
KLP
CC
MCM
FCM
DCM
Archon Capital Management's STIM Position: Q3 2024 in Review
Archon Capital Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 2,473,269 shares — an estimated $4.45M sold.
Archon Capital Management first reported a position in STIM in Q3 2020 and held it in 16 quarters. The position peaked at $21.2M in Q2 2021. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.
- Archon Capital Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
- Archon Capital Management sold 2,473,269 Neuronetics shares in Q3 2024, an estimated $4.45M.
- Archon Capital Management first reported a position in Neuronetics in Q3 2020 and held it in 16 quarters.
- Archon Capital Management's Neuronetics position peaked at $21.2M in Q2 2021.
- 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.
Based on Archon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.